Metastatic Breast Cancer — Current and Future Integration of Antibody-Drug Conjugates

Research To Practice | Oncology Videos · Oct 21, 2025 · 56m

Featuring perspectives from Dr Aditya Bardia and Dr Adam M Brufsky, including the following topics:

Introduction: Antibody-drug conjugates in localized breast cancer (0:00)

Case: A frail woman in her late 70s with ER-positive, HER2-low metastatic breast cancer (mBC) receives sacituzumab govitecan after multiple lines of therapy — Eric Fox, DO (7:46)

Case: A woman in her early 60s with NTRK-mutant ER-negative, HER2-low recurrent mBC receives trastuzumab deruxtecan — Lai (Amber) Xu, MD, PhD (21:07)

Case: A woman in her mid 70s with PIK3CA-mutant recurrent metastatic triple-negative breast…